StockData

Oaktree Acquisition Corp. III Life Sciences (OACC) shareholders

OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)

Close on Nov 17, 2026Market cap $263.53MP/E –Yield –

Ownership

Who owns Oaktree Acquisition Corp. III Life Sciences's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Oaktree Capital Group Holdings GP, LLC
Joint filing with Oaktree Acquisition Holdings III LS, LLC (22.30%), Oaktree Acquisition Holdings III LS GP, Ltd. (22.30%) and 1 more
5,500,53522.30%13G (passive)Dec 31, 2024
AQR Capital Management Holdings, LLC
Joint filing with AQR Capital Management, LLC (7.33%), AQR Arbitrage, LLC (7.33%)
1,450,7507.33%13G (passive) amendmentMar 31, 2025
Barclays PLC1,384,8106.99%13G (passive)Jun 30, 2026
The Goldman Sachs Group, Inc.
Joint filing with Goldman Sachs & Co. LLC (6.20%)
1,228,5006.20%13G (passive)Mar 31, 2026
Decagon Asset Management LLP
Joint filing with Benjamin John Durham (5.52%)
1,091,3275.52%13G (passive)Jun 30, 2026
Steven Patrick Pigott
Joint filing with Fort Baker Capital Management LP (5.10%), Fort Baker Capital, LLC (5.10%)
1,000,0005.10%13G (passive)Mar 31, 2026

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1 funds held OACC in Q2 2026, 100% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of OACCValue% of fundAs of
Horizon Kinetics SPAC Active ETF50,006–$535.56K5.31%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
George Arthur MartinezChief Financial Officer–Oct 29, 2025
Thomas SweeneyChief Financial Officer–Jun 16, 2025
David A. BerryDirector–Oct 22, 2025
Oaktree Acquisition Holdings III LS, LLC10% owner5,383,739Oct 23, 2026
Oaktree Capital Holdings, LLC10% owner550,000Oct 23, 2026
Oaktree Acquisition Holdings III LS GP, Ltd.10% owner–Oct 23, 2026
Capital Management Lp Oaktree10% owner–Oct 23, 2026
Oaktree Capital Management GP, LLC10% owner–Oct 23, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Oaktree Acquisition Holdings III LS, LLC
10% owner
Oct 23, 2026Conversion+4,798,758––5,382,739
Oaktree Acquisition Holdings III LS, LLC
10% owner
Oct 30, 2024Conversion+33,981$10.00$339.81K583,981

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+586.0%
From 0M shares
Short volume, 20 days
29.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Oaktree Acquisition Corp. III Life Sciences's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?